After a 10 day pause, the CDC and FDA have recommended the resumption of the single shot Johnson & Johnson vaccine which will likely happen tomorrow.
Fifteen women who received the J&J vaccine developed blood clots which resulted in three deaths. Women between the age of 18-49 have a 7 in a million chance of developing these clots. While women might be more inclined to get the Pfizer or Moderna vaccine, the benefits of the J&J vaccine outweigh the risks.
Although there were many who thought this pause was unnecessary, as I argued at the time the J&J vaccine, I think the pause will ultimately prove to be a bump in the road.
No comments:
Post a Comment